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INTRODUCTION
The cellular and subcellular targets and the mechanisms
of action of estrogen and progesterone in human skin pig-
mentation are largely unknown. Only a few studies have
examined the actions of estrogen and progesterone on the
epidermal microenvironment. Most of the actions of female
sex hormones appear to be exerted via their specific receptors
on target cells and intracellular receptors that function as li-
gand-activated transcription factors, regulating the synthe-
sis of specific RNAs and proteins. Human  progesterone
receptors (PR) have been identified in normal keratinocytes
(1).
High estrogen levels in the serum have been reported to
be associated with an increase in skin pigmentation (2). How-
ever, it is unclear whether the sex hormones play a significant
role in the proliferatiom of cultured human melanocytes and
their tyrosinase activity.
The issue of melanocytic expression via estrogen receptors
(ER) has been quite controversial (3, 4). Although many
researchers have shown the ability of melanocyte to bind to
the hormones, such as estrogen and progesterone, using a
hormone-binding assay, true hormone receptors have not
been molecularly identified in human melanocytes (5, 6).
The present study used immunocytochemistry and reverse
transcriptase polymerase-chain reaction (RT-PCR) to deter-
mine the ER and PR status in cultured melanocytes and the
effects of estrogen and progesterone in human pigmentation
in vitro in an attempt to elucidate the mechanism of the
pregnancy-induced pigmentation, melasma.
MATERIALS AND METHODS
Melanocyte culture
Normal human melanocytes were derived from the adult
foreskin as previously described (7) and maintained in a
growth medium consisting of MCDB-153, 4% heat-inacti-
vated fetal bovine serum (FBS) (Gibco BRL, Grand Island,
NY, U.S.A.), 10-7 M  -melanocyte stimulating hormone
( -MSH) (Sigma Chemical Co., St. Louis, MO, U.S.A.), 8
nM 12-O-tetradecanoyl phorbol 13-acetate (TPA) (Sigma
Chemical Co., St. Louis, MO, U.S.A.), 0.6 ng/mL human
recombinant basic fibroblast growth factor (FGF) (Cal-
biochem, San Diego, CA, U.S.A.), 5  g/mL insulin (Sigma
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Donor Specific Response of Estrogen and Progesterone on Cultured
Human Melanocytes
The mechanisms of estrogen and progesterone in human cutaneous pigmenta-
tion are largely unknown. The molecular identification of estrogen receptor (ER)
and progesterone receptor (PR) in the human melanocytes is of great importance
to understand the mechanisms. We performed immunocytochemistry analysis
and demonstrated that ER and PR were expressed in the cytoplasms and nuclei
of human melanocytes. Reverse transcriptase-polymerase chain reaction (RT-
PCR) and sequence analysis confirmed the expression of ER and PR at the
transcriptional level. Despite of the presence of ER and PR, the physiological
and pregnant levels of estrogen and progesterone showed inconsistent effects
on the proliferation and tyrosinase activity of cultured human melanocytes. These
results suggest that human melanocytes express ER and PR, which have a donor-
specific action in human pigmentation. Further studies are needed to elucidate
the induction mechanism and functions of these receptors, and the role of estro-
gen and progesterone in melanocytes.
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pherol (Sigma Chemical Co., St. Louis, MO, U.S.A.), and
1% penicillin-streptomycin (10,000 units/mL and 10,000  g/
mL, respectively) (Sigma Chemical Co., St. Louis, MO,
U.S.A.).
All the subjects were Korean with Fitzpatrick skin type
between III-VI. In all experiments for the expression of ER
and PR, the melanocytes were maintained in culture MCDB
153 with chelexed FBS (Hyclone, Logan, UT, U.S.A.) and
lacking  -MSH for 3 days prior to beginning. Conventional
FBS were reported to have estrogen.
Immunocytochemistry of ER and PR
Melanocytes grown on Lab-Tek chambers were fixed in 4%
paraformaldehyde for 30 min at room temperature, and per-
meated in methanol followed by 0.1% Triton X-100 to achieve
a nuclear permeance. Slides were placed in methanol contain-
ing 0.3% hydrogen peroxidase for 10 min and the tissue non-
specific activity was blocked by normal goat serum for 10
min. Then they were incubated with mouse monoclonal
primary antibody against recombinant protein correspond-
ing to the full-length estrogen receptors (Novocastra, Clare-
mont Palace, U.K.) overnight at 0℃ at 1:40 dilution. Bio-
tinylated antibody both against mouse and rabbit (DAKO,
Carpinteria, CA, U.S.A.), was applied for 20 min. Subse-
quently, the slides were incubated with streptavidin peroxi-
dase (DAKO, Carpinteria, CA, U.S.A.), for 20 min at room
temperature. The substrate chromogen 3-amino-9-ethyl-
carbazole (AEC) (Biomeda Corp., Foster city, CA, U.S.A.),
was applied for approximately 20 min. The sections were
counterstained with Mayer hematoxylin (Merck, Darmstadt,
Germany), and mounted with universal mount. Negative
controls were made by applying phosphate-buffered saline
(PBS) instead of the primary antibody. They consistently
yielded the negative results. MCF-7 cell line grown on the
LabTek chamber were used as a positive control (8).
Reverse Transcriptase-Polymerase Chain Reaction
Total RNA was extracted from cells by using a silica gel-
based membrane (RNeasy total RNA kits; QIAGEN, Chat-
sworth, CA, U.S.A.) and incubated for 15 min at room tem-
perature with 1 U RNase-free DNase I (Gibco BRL, Grand
Island, NY, U.S.A.), to remove contaminating genomic DNA.
Following inactivation of DNase I with ethylenediamine
teraacetic acid (EDTA), the samples were heated and 3  g of
total RNA was reverse-transcribed using Oligo-dT and
Superscript II RNase H reverse-transcriptase (Gibco BRL,
Grand Island, NY, U.S.A.). One tenth of RT product was
mixed with 22 mM Tris-HCl (pH 8.4), 55 mM KCl, 165
mM MgCl2, 0.2 mM each of dATP, dCTP, dGTP, and dTTP,
22 U recombinant Taq DNA polymerase (PCR SuperMix
system; Gibco BRL, Grand Island, NY, U.S.A.), and 0.5  M
each of the sense and anti-sense primer pairs. The following
deoxyoligonucleotides were used as specific primers for the
PCR. Human PR (9), sense 5′ -TGGCTAAAGTGGTGCA
TGAT-3′ , anti-sense 5′ -GTTTCACCATCCCTGCCAAT-3;
human ER (10), sense 5′ -GCACCCTGAAGTCTCTGG
AA-3′ , anti-sense 5′ -TGGCTAAAGTGGTGCATGAT-3′ ;
GAPDH, sense 5′ -GGTCGGAGTCAACGCATTTG-3′ ,
anti-sense 5′ -ATGAGCCCCAGCCTTCTCCAT-3′ . After
heating the mixtures at 94℃ for 2 min, the PCR reaction
was performed for 35 cycles [30 sec at 94℃, 30 sec at 65℃
(PR and GAPDH) or 55℃ (ER), and 2 min at 72℃]. PCR
products were visualized with ethidium bromide staining
(Promega, Madison, WI, U.S.A.).
DNA Sequencing
Amplified PCR products were electrophoresed on a 2%
agarose gel. The cDNA fragments were eluted from the
agarose gel slices by a QIAquick gel extraction kit (QIA-
GEN, Chatsworth, CA, U.S.A.). Single strand DNA tem-
plate was purified by a Big Dye Terminator cycle sequenc-
ing kit (Perkin-Elmer, Norwalk, CT, U.S.A.). Sequencing
reactions were performed using the dideoxy chain-termina-
tion method and analyzed, using an ABI 733 sequencer
(Perkin-Elmer, Norwalk, CT, U.S.A.).
Skin organ culture
Normal skin of the breast cancer patients during the mas-
tectomy were used for organ culture. All the skin samples
were used immediately after the excision. Subcutaneous fat
was removed and discs were taken from the skin samples
with a 4-mm punch biopsy. Each skin sample was placed
on a millicelles (1.2  m pore size, Millipore, Bedford, MA,
U.S.A.) and then inserted on a 24-well culture plate in such
a way that the medium was only in contact with the dermal
side of the sample so that the epidermis remained constantly
exposed to the air. Each piece was maintained in a DMEM
medium lacking phenol-red (Gibco BRL, Grand Island,
NY, U.S.A.) and containing 10% Chelexed FBS (Hyclone,
Logan, UT, U.S.A.). Phenol-red and conventional FBS were
reported to have an estrogenic stimulatory effect. Treatment
with estrogen and progesterone (1 and 100 nM each) and
medium change were performed every other day for 6 days.
At 6th day, the cultures were fixed in 4% buffered formalde-
hyde and embedded in paraffin. Routine hematoxylin and
eosin stain and Fontana-Masson stain were done on each
sample.
Determination of melanocyte proliferation and tyrosi-
nase activity after treatment with estrogen and pro-
gesterone
To investigate the effects of estrogen and progesterone on
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were plated at a density of 1.5×10
6 cells/60-mm dish. The
culture medium was replenished, and a fresh treatment (1,
100 nM estrogen and progesterone) was done every other day
for a total of 6 days. At the end of each experiment, melano-
cytes from each individual dish were harvested and counted
using a Coulter counter (Coulter Electronics, Hialcah, FL,
U.S.A.). During the final 24 hr of the experiment, (3, 5-3H)
L-tyrosine (specific activity, 52 mCi/mmol; Dupont NEN,
Boston, MA, U.S.A.), at a concentration of 0.7  Ci/ mL (total
of 2.1  Ci/3 mL/flask) was added to the culture medium.
The conditioned medium from each well was then saved to
determine tyrosinase activity. The tyrosine hydroxylase activi-
ty was determined in situ by a modification of the Pomer-
antz charcoal absorption method as previously described (11).
This assay is based on the measurement of the amount of
3H2O released into the culture medium as [3H]tyrosine is
converted to L-dihydroxyphenylalanine (L-DOPA) by tyro-
sinase.
RESULTS
Expression of ER and PR in the cultured melanocytes
Melanocytes grown on slides were analyzed by immunos-
taining using the same human ER and PR antibodies. The
human adult melanocytes expressed ER and PR in the cyto-
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Fig. 1. Immunocytochemistry of ER and PR in cultured melanocytes
(original magnification, ×400). A: Melanocyte-negative control.
B: Melanocyte-ER positive (arrow). Cultured melanocytes show
cytoplasmic and nuclear immunoreactivity. C: Melanocyte-PR
positive (arrowhead). Cultured melanocytes show cytoplasmic
and nuclear immunoreactivity.plasm and nucleus (Fig. 1). The human breast cancer cell
line MCF-7 shows positive ER and PR immunoreactivity
in the nucleus (data not shown) (12, 13).
To confirm that the ER and PR immunoreactivity was
originated from the encoded proteins, we subsequently exam-
ined the ER and PR transcripts by PCR. The predicted 195
bp and 470 bp PCR products of PR and ER, respectively,
were found in MCF-7 and human adult melanocytes (Fig.
2). Neonatal melanocytes expressed the same immunoreactiv-
ity and mRNA transcripts of ER and PR (data not shown).
Sequencing analysis of the RT-PCR products of ER and PR
showed 99.9% homology with the reported human ER and
PR sequences (data not shown). These results confirmed that
mRNA coding for ER and PR is transcribed and translated
in human melanocytes, providing a strong evidence that
human melanocytes are the target for the estrogen and pro-
gesterone action.
Effect of estrogen and progesterone on pigmentation
in skin samples grown in organ culture
To investigate the influence of estrogen and progesterone
on pigmentation, skin organ culture was used as a model
system more closely resembling in vivo circumstances than
those of the melanocyte monolayer culture. Because the steroid
hormones are capable of penetrating the skin easily as com-
pared with the peptide hormones, the skin explants were
first immersed in the media and estrogen and progesterone
were treated for 6 days. During the culture, the overall in
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Fig. 2. RT-PCR profiles of cultured human melanocyte. RT-PCR of
MCF-7 and human melanocytes yielded the predicted 195 bp
PCR product for PR and 470 bp for ER at mRNA level. Lane 1,
molecular size marker, Lane 2, GAPDH (MCF-7), Lane 3, GAPDH
(melanocyte), Lane 4, ER ( MCF-7), Lane 5, ER (melanocyte), Lane
6, PR (MCF-7), Lane 7, PR (melanocyte), Lane 8, molecular size
marker.
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Fig. 3. Effect of estrogen and progesterone on pigmentation in skin samples grown in organ culture. Estrogen and progesterone at a
physiologic concentration (1 nM) and concentration in pregnancy (100 nM) did not show any significant epidermal changes including the
thickness and rete ridge pattern. The concentrations also did not affect the epibolic outgrowth. In 2 samples out of 5, estrogen at 1 nM
and 100 nM concentration increased the basal pigmentation as compared with the control. However, progesterone either at 1 nM or at
100 nM concentration did not increase the melanin content in the epidermis in all samples. A: control, B: estrogen at 100 nM concentra-
tion increased the basal pigmentation (Fontana-Masson stain, original magnification, ×400).vivo cell morphology of keratinocytes was maintained for a
period of 6 days. Although a slight dermoepidermal separa-
tion was noted in some experiment, the explants were quite
satisfactory for testing. Epidermal cells of the explant prolif-
erated and migrated to form a new epidermis (epibolus) that
completely surround the explant within 6 days. Estrogen and
progesterone either at a physiologic concentration (1 nM) or
at a concentration in pregnancy (100 nM) did not show any
significant epidermal changes including the thickness and
rete ridge pattern. The concentrations did not affect the epi-
bolic outgrowth, either. In 2 samples out of 5, estrogen at 1
nM and 100 nM concentration both increased the basal pig-
mentation as compared with the control (Fig. 3). However,
progesterone either at 1 nM or at 100 nM concentration did
not increase the melanin content in the epidermis in all sam-
ples.
Melanogenic and mitogenic effects of estrogen and
progesterone on human melanocytes
Because conventional FBS and phenol red in MCDB media
have a mild estrogenic effect, we first maintained the cultured
melanocytes in phenol red-free DMEM with chelexed serum
that was deprived of estrogen by charcoal. In this condition,
melanocytes started to float on day 4 and we could not main-
tain the melanocytes more than 6 days. We next compared
the effect of estrogen and progesterone on melanocytes in
MCDB with phenol red and chelexed serum vs regular serum,
and observed no difference. Thus the subsequent experiments
were done using MCDB with chelaxed serum.
Melanocytes from 8 donors treated with 1 and 100 nM
estrogen and progesterone for 6 days showed a donor-specif-
ic response (Table 1). The number of melanocytes and tyro-
sine hydroxylase activity increased in melanocytes from 3
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Fig. 4. Effect of estrogen and progesterone on the proliferation and tyrosinase activity of human melanocytes. A: The number of
melanocytes and tyrosine hydroxylase activity both increased in melanocytes from AM-2 donor in response to 1 and 100 nanomolar
concentrations of estrogen and progesterone. B: Neither proliferation nor tyrosinase activity showed any changes due to estrogen
and progsterone treatment in AM-6 donor.
AM-1 AM-2 AM-3 AM-4 AM-5 AM-6 AM-7 AM-8
E 1 nM Proliferation 119.78±9.01 138.97±12.88 122.47±10.15 96.20±3.37 84.58±8.81 109.10±14.67 93.03±9.50 96.29±5.63
THA 110.68±2.75 151.05±6.77 207.45±2.19 89.08±15.17 103.29±5.81 99.66±5.41 100.70±13.34 121.29±10.25
E 100 nM Proliferation 108.79±1.83 144.32±3.79 129.46±12.75 99.18±4.36 93.19±10.69 103.81±11.77 99.16±11.25 84.16±7.69
THA 115.83±4.61 134.84±7.29 191.06±6.85 98.04±14.55 109.54±8.78 96.15±9.11 96.29±8.95 135.56±10.96
P 1 nM Proliferation 123.43±2.38 138.61±6.07 145.98±8.65 98.21±5.10 93.45±4.16 114.86±15.44 106.25±8.54 108.61±10.24
THA 117.54±8.10 131.27±11.20 187.68±0.94 112.58±18.96 91.83±16.74 90.67±7.96 103.55±10.82 122.41±9.73
P 100 nM Proliferation 141.45±5.68 147.39±9.79 127.59±1.51 99.73±2.82 103.45±3.70 113.22±4.56 92.57±3.71 93.23±4.04
THA 116.78±0.69 146.91±7.74 197.24±2.99 113.01±23.66 98.90±3.10 97.57±8.13 108.57±12.81 126.63±8.69
Table 1. Melanogenic and mitogenic effects of estrogen and progesterone on cultured human melanocytes (% of untreated control)
Cells were plated at 1.5×10
6 cells/60-mm dish, and triplicate dishes were included in each of the control and experimental groups. Fresh growth
medium with 1 nM and 100 nM concentrations of estrogen (E) and progesterone (P) each was added to each dish every other day for a total of 6
days. For proliferation, melanocytes from each individual dish were harvested at the end of experiment and counted using a Coulter counter, and %
of control was calculated. In the same experiment, tyrosine hydroxylase activity was assayed on day 6. On day 5, each dish was incubated with a
medium containing [
3H] tyrosine for 24 hr. The conditioned medium from each dish was then collected and assayed for tyrosine hydroxylase activity.
For THA, tyrosine hydroxylase activity was expressed as DPM/10
7 cells and % of untreated control was calculated. This experiment was repeated
three times, which yielded similar results. The values indicated are the means and SD of % of control in each experiment performed in triplicate.
Melanocytes treated for 6 days with 1 and 100 nM estrogen and progesterone in 8 different donors showed a donor-specific response.adult foreskin donors in response to 1 and 100 nM estrogen
and progesterone, respectively (Fig. 4A). In one donor, only
the tyrosinase activity increased. In the remaining 4 donors,
neither proliferation nor tyrosinase activity of melanocytes
showed any significant changes due to estrogen and proges-
terone (Fig. 4B). Interestingly, the dose response to 1 and
100 nanomolar concentrations of either hormone did not
show any significant differences.  -MSH treatment, used
for a positive control, was proved to be both mitogenic and
melanogenic in melanocytes. However when  -MSH was
treated concomitantly with estrogen and progesterone, no
additive response was observed, and no difference was noted
between neonatal and adult melanocytes (data not shown).
DISCUSSION
Since many dermatoses are related to a female predisposi-
tion and pregnancy, it is feasible that the female sex hormone
may influence the skin directly. Estrogen appears to increase
the vascularization of the skin and suppress the sebaceous
gland activity. Also estrogen increases the pigment cell
activity (14).
Skin pigmentation in vivo is determined by genetic, envi-
ronmental, local, and endocrine factors, which influence both
melanin synthesis within each melanocyte and the distribu-
tion of melanin throughout the epidermis. Melasma, a com-
mon acquired brownish pigmentation occurring exclusively
in the sun-exposed areas on the face, is exacerbated by preg-
nancy and oral contraceptives (15-20). Sato reported a signifi-
cantly high level of progesterone in the serum of Japanese
patients with melasma (2). On the other hand, Perez et al.
reported the increased serum levels of LH alone, and lower
levels of serum estradiol in patients with melasma than in
normal controls (21). We, therefore, assumed that the ovarian
hormones such as estrogen and progesterone may be involved
in the pathogenesis of melasma, i.e., indirect influence of
ovarian hormones on the melanocytes in vivo remains to be
clarified.
The issue of melanocytic expression via ER has been quite
controversial. Investigators found that tyrosinase can mimic
the tight binding of 3H-estradiol, giving 3H-labeled prod-
ucts. In this way tyrosinase oxidation of 3H-estradiol led to
spurious positive results in early biochemical assays of estro-
gen binding. Although the true estradiol binding could not
be distinguished from tyrosinase activity with the dextran-
coated charcoal assay, the use of immunocytochemistry and
RT-PCR obviated this problem.
In this study we provide the first direct evidence that
human melanoytes show ER and PR immunoreactivity. ER
and PR belong to a superfamily of ligand-induced transacti-
vators that exerts their regulatory activity on discrete genes
through DNA binding at individual hormone-responsive
elements. Understanding the molecular characterization of
ER and PR is of particular importance in assessing the hor-
monal dependence of target cells. The significance of ER and
PR in the melanocytes is an area of considerable interest. To
clarify the existence of ER and PR, we analyzed the expression
of ER and PR in cultured melanocytes and designed an exper-
iment to evaluate the role of estrogen and progesterone on
human pigmentation using an in vitro culture system. Our
data provides the evidence for the presence of ER and PR in
cultured melanocytes by immunocytochemistry, RT-PCR,
and sequencing.
Recent studies have demonstrated the effects of estrogen
and progesterone on human melanocytes. However, it is
unclear whether the effects were directly exerted by the sex
hormones or by tyrosinase activity.
Ranson et al., for the first time, reported that the incuba-
tion of neonatal melanocytes with beta-estradiol (10
-10-10
-9
M) for 24 hr resulted in a dose-dependent stimulation of
the tyrosinase activity (22). The increased melanogenesis
was accompanied by reduced cell number and enhanced
melanin extrusion into the medium. They are also aware that,
most studies on the melanocytes have extrapolating any of
the results to the adult situation.
On the contrary, Jee et al. reported that the treatment of
17 -estradiol (10
-12 to 10
-9 M) for 10 days significantly showed
the increased neonatal melanocyte number, and for 1 day
exhibited the decreased tyrosinase activity and melanin con-
tent (6). However, they suggested that the tyrosinase activi-
ty and melanin content were expressed on per cell bases. It is
suggested that the proliferating activity stimulated by estra-
diol was greater than that by the tyrosinase activity and the
melanin producing activity.
Recent data from the adult melanocytes of Japanese male
foreskin showed that estradiol in the concentration range of
0.01 to 1.0  g/mL and 1 g/mL progesterone significantly
increased the amount of TRP-1, and no significant effect on
DOPA oxidase activity was detected after estradiol and pro-
gesterone treatment (23). Estradiol and progesterone also
increased the area, the dendrites and the perimeter per cell.
Kippenberger et al. applied the reverse transcriptase-com-
petitive multiplex PCR to normal human melanocytes, and
reported that 20  M treatment of diethylstilbestrol and estra-
diol for 48 hr lead to an increase of about 1.5 to 2.5 fold of
tyrosinase and TRP-2 transcripts (24). The authors reported
for the first time that the sex steroids cause an increase of
melanogenic enzyme transcripts in normal human mela-
nocytes. An increase in the tyrosinase activity could provoke
the switch from pheomelanogenesis to eumelanogenesis.
Activation of tyrosinase by estradiol might be an alternative
to a direct receptor-mediated mechanism for the growth
inhibitory effect observed in vivo and in vitro.
In this study, in spite of the presence of receptor for estro-
gen and progesterone, they had a donor-specific effect on
proliferation of melanocytes. There are several plausible
explanations for this lack of effect on melanocyte growth in
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respond to estrogen and progesterone with a stimulation of
growth. The genetic predisposition and ultraviolet exposure
may be prerequisite or costimulating factors. Alternative
explanations for the lack of either a stimulatory response to
estrogen and progesterone in vitro include the limited amount
of receptor present, a requirement for an estrogen- or pro-
gesterone-induced autocrine or paracrine growth factor-
mediated growth. The dilution of such factors in culture has
been proposed to account for the observed absence of estro-
gen- or progesterone-stimulated cell growth in the breast
tumor cells that otherwise respond to estrogen and proges-
terone in vivo by increased tumor growth.
We provide the first direct evidence that human cultured
melanoytes contain ER and PR immunoreactivity. Human
melanocytes uniformly expressed ER and PR in their cyto-
plasm and nucleus. ER and PR mRNA were present in cul-
tured melanocytes. In spite of the presence of receptor for
estrogen and progesterone, estrogen and progesterone had a
donor-specific effect on proliferation of melanocytes and
tyrosine hydroxylase activity.
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